[Federal Register Volume 86, Number 14 (Monday, January 25, 2021)]
[Notices]
[Pages 6949-6950]
[FR Doc No: 2021-01425]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2021-0009]

Notice of Application for Approval of Discontinuance or
Modification of a Railroad Signal System

    Under part 235 of title 49 Code of Federal Regulations (CFR) and 49
U.S.C. 20502(a), this document provides the public notice that on
January 7, 2021, Norfolk Southern Corporation (NS) petitioned the
Federal Railroad Administration (FRA) seeking approval to discontinue
or modify a signal system. FRA assigned the petition Docket Number FRA-
2021-0009.

Applicant: Norfolk Southern Corporation, Tommy A. Phillips, Senior
Director--C&S Engineering, 1200 Peachtree Street NE, Atlanta, GA 30309

    Specifically, NS requests permission to discontinue a traffic
control system (TCS) on the T and TC lines, milepost (MP) 0.0T to MP
40.0T and MP 40.0TC to MP 87.0TC, from Andover to Bulls Gap on the Blue
Ridge Division. This includes control points (CP) at Big Stone, Jasper,
Tito, Glenita, Watkins, Boone, Smith, Yuma, Click, Lamb, Church Hill,
Surgoinsville, Hawkins, Burem, Hogan, McCloud, Summit, Moore, Ward,
Haun, and 18 automatic signal locations. The main track between MP 0.0T
and MP 40.0T and MP 40.0TC and MP 87.0TC will be converted to NS Rule
171 operation. Two operable approach signals will be installed at MP
43.8TC and MP 48.3TC. The signaled sidings within the application area
will be made non-controlled, other than main track.
    NS states the reason for the proposed discontinuance is that
operations no longer require TCS.
    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested parties
desire an opportunity for oral comment and a public hearing, they
should notify FRA, in writing, before the end of the comment period and
specify the basis for their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be

submitted by any of the following methods:
     Website: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation (DOT), 1200 New Jersey Ave. SE, W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Ave. SE, Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal Holidays.
    Communications received by March 11, 2021 will be considered by FRA
before final action is taken. Comments received after that date will be
considered if practicable.
    Anyone can search the electronic form of any written communications
and comments received into any of our dockets by the name of the
individual submitting the comment (or signing the document, if
submitted on behalf of an association, business, labor union, etc.).
Under 5 U.S.C. 553(c), DOT solicits comments from the public to better
inform its processes. DOT posts these comments, without edit, including
any personal information the commenter provides, to
www.regulations.gov, as described in the system of records notice (DOT/
ALL-14 FDMS), which can be reviewed at https://www.transportation.gov/privacy. See also https://www.regulations.gov/privacyNotice for the
privacy notice of regulations.gov.

    Issued in Washington, DC.
John Karl Alexy,
Associate Administrator for Railroad Safety, Chief Safety Officer.
[FR Doc. 2021-01425 Filed 1-22-21; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register Volume 81, Number 53 (Friday, March 18, 2016)]
[Notices]
[Pages 14917-14919]
[FR Doc No: 2016-06096]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-77356; File No. SR-NYSEMKT-2016-36]

Self-Regulatory Organizations; NYSE MKT LLC; Notice of Filing and
Immediate Effectiveness of Proposed Rule Change To Extend the Deadline
for Implementing Rule 967.1NY(a)(2) and (3)

March 14, 2016.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby
given that on March 4, 2016, NYSE MKT LLC (the ``Exchange'' or ``NYSE
MKT'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to extend the deadline for implementing Rule
967.1NY(a)(2) and (3) until July 31, 2016. The proposed rule change is
available on the Exchange's Web site at www.nyse.com, at the principal
office of the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange is proposing to extend the deadline for implementing
Rule 967.1NY(a)(2) and (3) until July 31, 2016. The current
implementation deadline is March 4, 2016.
    In March 2015, the Commission approved Rule 967.1NY, which provides
a price protection risk mechanism for Market Maker quotes.\4\ Rule
967.1NY provides two layers of price protection to incoming Market
Maker quotes, rejecting those Market Maker quotes that exceed certain
parameters, as a risk mitigation tool.\5\ The Exchange has implemented
the first layer of price protection (the NBBO Reasonability Check) and
has until one year from the date of the Approval Order to implement the
second layer of protection (the Underlying Stock Price/Strike Price
Check) pursuant to Commentary .01 to Rule 967.1NY, which is March 4,
2016 (the ``March 4th Deadline'').\6\
---------------------------------------------------------------------------

    \4\ See Securities Exchange Act Release No. 74440 (March 4,
2015), 80 FR 12687 (March 10, 2015) (SR-NYSEMKT-2014-116) (Approval
Order); see also Securities Exchange Act Release No. 74017 (January
8, 2015), 80 FR 1979 (January 14, 2015) (SR-NYSEMKT-2014-116)
(Notice).
    \5\ The first layer of price protection assesses incoming sell
quotes against the NBB and incoming buy quotes against the NBO (the
``NBBO Price Reasonability Check''). Specifically, per Rule
967.1NY(a)(1), provided that an NBBO is available, a Market Maker
quote would be rejected if it is priced a specified dollar amount or
percentage through the contra-side NBBO. The second layer of price
protection assesses the price of call or put bids against a
specified benchmark (the ``Underlying Stock Price/Strike Price
Check''), per Rule 967.1NY(a)(2) and (3). This second layer of
protection applies to bids in call options or put options when (1)
there is no NBBO available, for example, during pre-opening or prior
to conducting a re-opening after a trading halt, or (2) if the NBBO
is so wide as to not reflect an appropriate price for the respective
options series.
    \6\ See Securities Exchange Act Release No. 75151 (June 11,
2015), 80 FR 34770 (June 17, 2015) (SR-NYSEMKT-2015-42).
---------------------------------------------------------------------------

    Because the Exchange has not yet implemented the Underlying Stock
Price/Strike Price Check, the Exchange proposes to modify Commentary
.01 to Rule 967.1NY to extend the March 4th Deadline to implement Rule
967.1NY(a)(2) and (3) until July 31, 2016. The Exchange has finalized
the technology related to this aspect of the Rule and will be filing
with the Commission a separate proposed rule change to modify the Rule
as it relates to the Underlying Stock Price/Strike Price Check. The
Exchange believes the proposed extension would provide the Exchange
with sufficient time to review the proposed modifications with the
Commission prior to implementing the rule, as modified.
    Finally, the Exchange believes that because the Underlying Stock
Price/Strike Price Check is an approved rule of the Exchange, providing
the Exchange with additional time to implement the Rule would ensure
that

Market Makers and investors are afforded the opportunity to benefit
from this price protection feature once it is implemented.
2. Statutory Basis
    The proposed rule change is consistent with Section 6(b) of the
Act,\7\ in general, and furthers the objectives of Section 6(b)(5),\8\
in particular, in that it is designed to promote just and equitable
principles of trade, to remove impediments to and perfect the mechanism
of a free and open market and a national market system, and in general,
to protect investors and the public interest.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78f(b).
    \8\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    Specifically, the Exchange believes the proposal promotes just and
equitable principles of trade and removes impediments to, and perfects
the mechanism of, a free and open market and a national market system
because an extension of the March 4th Deadline would enable the
Exchange to implement the finalized technology related to the
Underlying Stock Price/Strike Price Check. Moreover, the proposed
extension would assist with the maintenance of a fair and orderly
market and protect investors and the public interest because it would
afford the Exchange additional time to file, and review, with the
Commission a proposed modification of the Rule as it relates to the
Underlying Stock Price/Strike Price Check prior to implementing the
rule, as modified.
    Finally, the Exchange believes that because the Underlying Stock
Price/Strike Price Check is an approved rule of the Exchange, providing
the Exchange with additional time to implement the Rule would ensure
that Market Makers and investors are afforded the opportunity to
benefit from this price protection feature once it is implemented--even
if in modified form.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. The proposed rule change is
not designed to address any competitive issues, but rather, to extend
the deadline for implementing the Underlying Stock Price/Strike Price
Check pending finalization of the technology associated with that
feature.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change does not (i) significantly affect
the protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative for 30
days from the date on which it was filed, or such shorter time as the
Commission may designate if consistent with the protection of investors
and the public interest, the proposed rule change has become effective
pursuant to Section 19(b)(3)(A) of the Act \9\ and Rule 19b-4(f)(6)
thereunder.\10\
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(3)(A).
    \10\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires the Exchange to give the Commission written notice of the
Exchange's intent to file the proposed rule change, along with a
brief description and text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission. The
Commission has waived this requirement in this case.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \11\ normally
does not become operative for 30 days after the date of filing.
However, pursuant to Rule 19b-4(f)(6)(iii),\12\ the Commission may
designate a shorter time if such action is consistent with the
protection of investors and the public interest. The Exchange has asked
the Commission to waive the 30-day operative delay so that the proposal
may become operative immediately upon filing. The Commission believes
that waiving the 30-day operative delay is consistent with the
protection of investors and the public interest as it will allow the
Exchange to immediately extend the implementation deadline for the
Underlying Stock Price/Strike Price Check without delay and provide the
Exchange additional time to implement the technology associated with
such price protection. Accordingly, the Commission hereby waives the
30-day operative delay requirement and designates the proposed rule
change as operative upon filing.\13\
---------------------------------------------------------------------------

    \11\ 17 CFR 240.19b-4(f)(6).
    \12\ 17 CFR 240.19b-4(f)(6)(iii).
    \13\ For purposes only of waiving the 30-day operative delay,
the Commission has also considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings to
determine whether the proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-NYSEMKT-2016-36 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEMKT-2016-36. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal

identifying information from submissions.
    You should submit only information that you wish to make available
publicly. All submissions should refer to File Number SR-NYSEMKT-2016-
36, and should be submitted on or before April 8, 2016.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\14\
---------------------------------------------------------------------------

    \14\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Robert W. Errett,
Deputy Secretary.
[FR Doc. 2016-06096 Filed 3-17-16; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register: September 29, 2006 (Volume 71, Number 189)]
[Notices]
[Page 57492]
[DOCID:fr29se06-60]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. TX06-2-003]

Aero Energy LLC; Notice of Filing

September 25, 2006.
    Take notice that on September 13, 2006, Eurus Energy America
Corporation (Eurus) filed an Affidavit of Mark Anderson, as evidence
showing that a portion of the Sagebrush Line is needed for Eurus'
future expansion plans, pursuant to the Commission's August 14, 2006
Order.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date.
Anyone filing a motion to intervene or protest must serve a copy of
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on October 4, 2006.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-16009 Filed 9-28-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Notices]
[Pages 61065-61066]
[FR Doc No: 2019-24527]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-4777]

Haemonetics Manufacturing, Inc.; Withdrawal of Approval of
Abbreviated New Drug Application of Anticoagulant Citrate Dextrose
Solution A, USP

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is
withdrawing approval of abbreviated new drug application (ANDA) BA
710497/0 for Anticoagulant Citrate Dextrose Solution A, USP (ACD-A), In
Plastic Bags, held by Haemonetics Manufacturing, Inc. Haemonetics
Manufacturing, Inc., requested in writing that the Agency's approval of
the application be withdrawn because the drug is no longer being
marketed and has waived its opportunity for a hearing.

DATES: Approval is withdrawn as of December 12, 2019.

FOR FURTHER INFORMATION CONTACT: Sana F. Hussain, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION: Haemonetics Manufacturing, Inc., 400 Wood
Rd., Braintree, MA 02184, has requested that FDA withdraw approval of
ANDA BA 710497/0, pursuant to Sec.  314.150(c) (21 CFR 314.150(c)),
because the drug is no longer being marketed. By its request,
Haemonetics Manufacturing, Inc., has also waived its opportunity for a
hearing. Withdrawal of approval of an application under Sec.
314.150(c) is without prejudice to refiling.

------------------------------------------------------------------------
              Application No.                     Proprietary name
------------------------------------------------------------------------
ANDA BA 710497/0..........................  Anticoagulant Citrate
                                             Dextrose Solution A, USP
                                             (ACD-A) In Plastic Bags.
------------------------------------------------------------------------

    Therefore, approval of the application listed in the table, and all
amendments and supplements thereto, is hereby withdrawn as of December
12, 2019. Introduction or delivery for introduction into interstate
commerce for products without an approved new drug application or ANDA
violates section 301(a) and (d) of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 331(a) and (d)). The drug product that is listed in the
table above that is in inventory on December 12, 2019 may continue to
be dispensed until the inventory has been depleted or the drug product
has reached its expiration date or otherwise becomes violative,
whichever occurs first.

    Dated: October 29, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-24527 Filed 11-8-19; 8:45 am]
 BILLING CODE 4164-01-P